Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Thomas Jefferson University
This study assesses feasibility and patient acceptability of using a Fitbit to monitor step count and heart rate in transfusion dependent patients with myelodysplastic syndrome. Information from this study may help researchers understand if there is any correlation between activity level and anemia.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Confirmed pathologic diagnosis of MDS
Requiring \>= 2 blood transfusions in the past month if previously diagnosed or hemoglobin =\< 8 g/dL if newly diagnosed
Age \>= 18
Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2
Ambulatory (use of a walking aid, such as a cane or rollator, is acceptable)
Able to give informed consent
Willing to comply with all study procedures and available for the duration of the study
Able to read and/or understand English
Have access to an iPhone 4S or later, iPad 3 generation or later, Android 5.0 or later, or Windows 10 device
Have access to Bluetooth low energy (LE) and internet connection for syncing
You may not be if
Uncontrolled illness including, but not limited to, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements
